Article Versions Notes

Asquith CRM, Godoi PH, Couñago RM, Laitinen T, Scott JW, Langendorf CG, Oakhill JS, Drewry DH, Zuercher WJ, Koutentis PA, et al. 1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors. Molecules. 2018; 23(5):1221. https://doi.org/10.3390/molecules23051221

Asquith, Christopher R. M., Paulo H. Godoi, Rafael M. Couñago, Tuomo Laitinen, John W. Scott, Christopher G. Langendorf, Jonathan S. Oakhill, David H. Drewry, William J. Zuercher, Panayiotis A. Koutentis, and et al. 2018. "1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors" Molecules 23, no. 5: 1221. https://doi.org/10.3390/molecules23051221

Asquith, C. R. M., Godoi, P. H., Couñago, R. M., Laitinen, T., Scott, J. W., Langendorf, C. G., Oakhill, J. S., Drewry, D. H., Zuercher, W. J., Koutentis, P. A., Willson, T. M., & Kalogirou, A. S. (2018). 1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors. Molecules, 23(5), 1221. https://doi.org/10.3390/molecules23051221